|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| A61K 31/501 | (2013.01) | ||
| C07D 405/14 | (2006.01) | ||
| A61K 31/502 | (2013.01) | ||
| C07D 413/14 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| C07D 401/12 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| C07D 403/14 | (2006.01) | ||
| A61K 31/551 | (2013.01) | ||
| C07D 409/14 | (2006.01) | ||
| C07D 237/20 | (2013.01) | ||
| C07D 401/04 | (2013.01) | ||
| C07D 417/14 | (2006.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 401/12 | (2013.01) | ||
| C07D 471/08 | (2006.01) | ||
| C07D 401/14 | (2013.01) | ||
| C07D 487/04 | (2006.01) | ||
| C07D 403/10 | (2013.01) | ||
| C07D 487/10 | (2006.01) | ||
| C07D 403/12 | (2013.01) | ||
| A61K 31/501 | (2006.01) | ||
| C07D 403/14 | (2013.01) | ||
| C07D 405/14 | (2013.01) | ||
| A61P 21/00 | (2006.01) | ||
| C07D 409/14 | (2013.01) | ||
| C07D 413/14 | (2013.01) | ||
| C07D 417/14 | (2013.01) | ||
| C07D 471/04 | (2013.01) | ||
| C07D 471/08 | (2013.01) | ||
| C07D 471/10 | (2013.01) | ||
| C07D 487/04 | (2013.01) | ||
| C07D 487/10 | (2013.01) | ||
| A61K 31/41 | (2013.01) | ||
| A61K 31/427 | (2013.01) | ||
| C07D 237/06 | (2013.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Patento numeris | 3564233 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18209821.0 |
| Europos patento paraiškos padavimo data | 2013-08-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-11-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-05-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261682448 P | 2012-08-13 | US |
| (72) |
CHEUNG, Atwood , US
CHIN, Donovan Noel , US
DALES, Natalie , US
FAZAL, Aleem , US
HURLEY, Timothy Brian , US
KERRIGAN, John , US
O'BRIEN, Gary , US
SHU, Lei , US
SUN, Robert , US
SUNG, Moo , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS |
| 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS |